A preliminary study of Parkinson’s gene therapy via sono-magnetic sensing gene vector for conquering extra/intracellular barriers in mice
Author(s) -
Chun-Yao Wu,
Rih-Yang Huang,
En-Chi Liao,
YuChun Lin,
Yi-Ju Ho,
ChienWen Chang,
HongLin Chan,
YingZu Huang,
Tsung-Hsun Hsieh,
ChingHsiang Fan,
ChihKuang Yeh
Publication year - 2020
Publication title -
brain stimulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.685
H-Index - 81
eISSN - 1935-861X
pISSN - 1876-4754
DOI - 10.1016/j.brs.2020.02.024
Subject(s) - gene delivery , transfection , genetic enhancement , microbiology and biotechnology , intracellular , neurotrophic factors , chemistry , biology , gene , biochemistry , receptor
Non-virus genetic treatment for Parkinson's disease (PD) via plasmid glial cell-line derived neurotrophic factor (pGDNF) has shown potential for repairing damaged dopaminergic neurons. However, development of this gene therapy is largely hampered by the insufficient transfection efficiency as a result of the cell membrane, lysosome, and cytoskeleton meshwork.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom